Nasdaq:US$15.81 (+0.12) | HKEX:HK$24.65 (-0.30) | AIM:£2.29 (-0.01)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 3 Oct 2013

Analyst briefing on Chi-Med’s pharmaceutical R&D business on 9 October 2013